Your browser doesn't support javascript.
loading
Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA.2 in Shanghai, February-June 2022.
Chen, Xinhua; Yan, Xuemei; Sun, Kaiyuan; Zheng, Nan; Sun, Ruijia; Zhou, Jiaxin; Deng, Xiaowei; Zhuang, Tingyu; Cai, Jun; Zhang, Juanjuan; Ajelli, Marco; Yu, Hongjie.
Afiliação
  • Chen X; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
  • Yan X; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China.
  • Sun K; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
  • Zheng N; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China.
  • Sun R; Division of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, MD, USA.
  • Zhou J; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
  • Deng X; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China.
  • Zhuang T; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
  • Cai J; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China.
  • Zhang J; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
  • Ajelli M; Key Laboratory of Public Health Safety, Ministry of Education, Fudan University, Shanghai, People's Republic of China.
  • Yu H; Shanghai Institute of Infectious Disease and Biosecurity, School of Public Health, Fudan University, Shanghai, People's Republic of China.
Emerg Microbes Infect ; 11(1): 2800-2807, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36205530

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged80 / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Limite: Aged80 / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2022 Tipo de documento: Article